CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,005,000 | -37.7% | 3,031,965 | -3.1% | 1.14% | -67.8% |
| Q2 2020 | $14,462,000 | -13.8% | 3,130,195 | -28.1% | 3.53% | +52.6% |
| Q1 2020 | $16,768,000 | +188.8% | 4,355,416 | +181.3% | 2.31% | +172.1% |
| Q4 2019 | $5,806,000 | -56.4% | 1,548,316 | -38.3% | 0.85% | -47.3% |
| Q3 2019 | $13,322,000 | -9.6% | 2,508,838 | -34.6% | 1.61% | -3.1% |
| Q2 2019 | $14,735,000 | -16.4% | 3,837,181 | +11.0% | 1.67% | -29.3% |
| Q1 2019 | $17,631,000 | +287.8% | 3,457,041 | +46.0% | 2.36% | +289.1% |
| Q4 2018 | $4,547,000 | -28.3% | 2,368,330 | +41.1% | 0.61% | +51.5% |
| Q3 2018 | $6,343,000 | +21.2% | 1,677,944 | 0.0% | 0.40% | +18.7% |
| Q2 2018 | $5,235,000 | +45.2% | 1,677,944 | +11.2% | 0.34% | +43.4% |
| Q1 2018 | $3,605,000 | -0.3% | 1,508,309 | +63.1% | 0.24% | -51.8% |
| Q4 2017 | $3,615,000 | – | 924,648 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |